Lactobacillus helveticus CM4
Lactobacillus helveticus CM4 is notable for its proteolytic activity, particularly its capacity to generate bioactive peptides during milk fermentation. In vitro studies have characterized the endopeptidases responsible for processing these peptides, and one randomized controlled trial investigated fermented milk containing L. helveticus (including this species) in adults with high-normal blood pressure or mild hypertension, examining blood pressure as an outcome measure. The genomic and biochemical work on CM4 provides mechanistic context for these laboratory observations, though strain-specific human clinical evidence remains limited to this single trial context. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 1 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 4 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
7 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 16093403 →Effect of Powdered Fermented Milk with Lactobacillus helveticus on Subjects with High-Normal Blood Pressure or Mild Hypertension· Journal of the American College of Nutrition · 2005